148 related articles for article (PubMed ID: 9167082)
1. A Bayesian formulation of the Kalman filter applied to the estimation of individual pharmacokinetic parameters.
Botsman K; Tickle K; Smith JD
Comput Biomed Res; 1997 Apr; 30(2):83-94. PubMed ID: 9167082
[TBL] [Abstract][Full Text] [Related]
2. Use of a common spreadsheet program to demonstrate the ability of Bayesian forecasting to estimate the pharmacokinetic parameters of antibiotics.
Brocks DR; Wang M
J Pharm Pharmacol; 2023 Oct; 75(10):1378-1387. PubMed ID: 37478874
[TBL] [Abstract][Full Text] [Related]
3. A Bayesian approach to tracking patients having changing pharmacokinetic parameters.
Bayard DS; Jelliffe RW
J Pharmacokinet Pharmacodyn; 2004 Feb; 31(1):75-107. PubMed ID: 15346853
[TBL] [Abstract][Full Text] [Related]
4. Assessing convergence of Markov chain Monte Carlo simulations in hierarchical Bayesian models for population pharmacokinetics.
Dodds MG; Vicini P
Ann Biomed Eng; 2004 Sep; 32(9):1300-13. PubMed ID: 15493516
[TBL] [Abstract][Full Text] [Related]
5. Prediction of serum vancomycin concentrations using one-, two- and three-compartment models with implemented population pharmacokinetic parameters and with the Bayesian method.
Wu G; Furlanut M
J Pharm Pharmacol; 1998 Aug; 50(8):851-6. PubMed ID: 9751448
[TBL] [Abstract][Full Text] [Related]
6. Performance comparison of first-order conditional estimation with interaction and Bayesian estimation methods for estimating the population parameters and its distribution from data sets with a low number of subjects.
Pradhan S; Song B; Lee J; Chae JW; Kim KI; Back HM; Han N; Kwon KI; Yun HY
BMC Med Res Methodol; 2017 Dec; 17(1):154. PubMed ID: 29191177
[TBL] [Abstract][Full Text] [Related]
7. Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.
Bustad A; Terziivanov D; Leary R; Port R; Schumitzky A; Jelliffe R
Clin Pharmacokinet; 2006; 45(4):365-83. PubMed ID: 16584284
[TBL] [Abstract][Full Text] [Related]
8. Non steady state and steady state PKS Bayesian forecasting and vancomycin pharmacokinetics in ICU adult patients.
Polard E; Le Bouquin V; Le Corre P; Kérebel C; Trout H; Feuillu A; Le Verge R; Mallédant Y
Ther Drug Monit; 1999 Aug; 21(4):395-403. PubMed ID: 10442692
[TBL] [Abstract][Full Text] [Related]
9. DosOpt: A Tool for Personalized Bayesian Dose Adjustment of Vancomycin in Neonates.
Tasa T; Metsvaht T; Kalamees R; Vilo J; Lutsar I
Ther Drug Monit; 2017 Dec; 39(6):604-613. PubMed ID: 29084032
[TBL] [Abstract][Full Text] [Related]
10. Bayesian hierarchical model for analyzing multiresponse longitudinal pharmacokinetic data.
Zhao L; Xia Z
Stat Med; 2017 Dec; 36(30):4816-4830. PubMed ID: 28960369
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetic analysis of amikacin and validation on neonates using Monte Carlo method.
Wang J; Liang WQ; Wu JJ; Pan CM
Acta Pharmacol Sin; 2000 Oct; 21(10):954-60. PubMed ID: 11501052
[TBL] [Abstract][Full Text] [Related]
12. A comparison of Monte Carlo-based Bayesian parameter estimation methods for stochastic models of genetic networks.
Mariño IP; Zaikin A; Míguez J
PLoS One; 2017; 12(8):e0182015. PubMed ID: 28797087
[TBL] [Abstract][Full Text] [Related]
13. [Bayesian forecasting of plasma vancomycin concentration using time-dependent pharmacokinetics].
Nakamura T; Wakaki N; Kimura Y; Goto N; Masada M
Yakugaku Zasshi; 1996 Nov; 116(11):876-83. PubMed ID: 8981831
[TBL] [Abstract][Full Text] [Related]
14. Using Hamiltonian Monte Carlo to estimate the log-linear cognitive diagnosis model via Stan.
Jiang Z; Carter R
Behav Res Methods; 2019 Apr; 51(2):651-662. PubMed ID: 29949073
[TBL] [Abstract][Full Text] [Related]
15. Peak Measurement for Vancomycin AUC Estimation in Obese Adults Improves Precision and Lowers Bias.
Pai MP; Hong J; Krop L
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28096158
[TBL] [Abstract][Full Text] [Related]
16. Estimation of population pharmacokinetics using the Gibbs sampler.
Best NG; Tan KK; Gilks WR; Spiegelhalter DJ
J Pharmacokinet Biopharm; 1995 Aug; 23(4):407-35. PubMed ID: 8882748
[TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetics/pharmacodynamics modeling: parametric and nonparametric methods.
Jelliffe R; Schumitzky A; Van Guilder M
Ther Drug Monit; 2000 Jun; 22(3):354-65. PubMed ID: 10850405
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous versus sequential pharmacokinetic-pharmacodynamic population analysis using an iterative two-stage Bayesian technique.
Proost JH; Schiere S; Eleveld DJ; Wierda JM
Biopharm Drug Dispos; 2007 Nov; 28(8):455-73. PubMed ID: 17847121
[TBL] [Abstract][Full Text] [Related]
19. Fitting Bayesian Stochastic Differential Equation Models with Mixed Effects through a Filtering Approach.
Chen M; Chow SM; Oravecz Z; Ferrer E
Multivariate Behav Res; 2023; 58(5):1014-1038. PubMed ID: 36848197
[TBL] [Abstract][Full Text] [Related]
20. Influence of erroneous patient records on population pharmacokinetic modeling and individual bayesian estimation.
van der Meer AF; Touw DJ; Marcus MA; Neef C; Proost JH
Ther Drug Monit; 2012 Oct; 34(5):526-34. PubMed ID: 22846895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
